Deep Brain Stimulation for Substance Use Disorders? An Exploratory Qualitative Study of Perspectives of People

Erika Versalovic1, Eran Klein, Sara Goering

  • 1From the Department of Philosophy, University of Washington, Seattle, WA (EV, EK, SG); Center for Neurotechnology, University of Washington, Seattle, WA (EV, EK, SG); Department of Neurology, Oregon Health and Science University School of Medicine, Portland, OR (EK); Butler Center for Research, Hazelden Betty Ford Foundation, Center City, MN (QN, KG); College of Computing, Massachusetts Institute of Technology, Cambridge, MA (MB); Department of Philosophy, Fordham University, New York, NY (LSS); Department of Neuroscience, University of Minnesota, Minneapolis, MN (MJT); Medical Discovery Team on Addiction, University of Minnesota, Minneapolis, MN (MJT, ASW); and Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN (ASW).

PubMed
Abstract

Related Concept Videos

Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Long-term Potentiation01:25

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when presynaptic neurons...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Prosopagnosia01:24

Prosopagnosia

Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...